The global yeast expression vector market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing demand for therapeutic and research applications in various industries such as biotechnology, pharmaceuticals, and food & beverages. The increasing number of clinical trials for new drugs is also driving the growth of this market.
The global yeast expression vector market by type is segmented into K. Lactis Expression Vectors, Pichia Pastoris Expression Vectors, Saccharomyces Cerevisiae Expression Vectors. The K. Lactis Expression Vector segment accounted for the largest share in 2018 owing to its high efficiency and low cost-effectiveness when compared with other types of vectors used in gene therapy applications such as Pichia Pastoris and Saccharomyces Cerevisiae vectors which are more expensive than K. Lactis vectors but have higher efficacy rates than K. Lactis vectors when it comes to gene therapy applications due to their ability to express large amounts of proteins or peptides that are difficult or impossible with other types of yeast expression vectors like Pichia Pastoris or Saccharomyces Cerevisiae expression vectors respectively.
Some Of The Growth Factors Of This Market:
- Increasing research and development activities in the field of biotechnology are also expected to fuel this market's growth over the forecast period (2017-2025).
- The increasing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases is also expected to drive this market's growth over the forecast period (2017-2025) 5) Increasing awareness about genetic disorders among patients and healthcare providers is also anticipated to fuel this market's growth over the forecast period (2017-2025).
Industry Growth Insights published a new data on “Yeast Expression Vector Market”. The research report is titled “Yeast Expression Vector Market research by Types (K. Lactis Expression Vectors, Pichia Pastoris Expression Vectors, Saccharomyces Cerevisiae Expression Vectors, Others), By Applications (Therapeutic, Research, Industrial), By Players/Companies Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), New England Biolabs (U.S.), Merck Millipore (U.S.), QIAGEN (Netherlands), Clontech Laboratories, Inc. (U.S.), DNA2.0 (U.S.), GenScript USA Inc. (U.S.)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Yeast Expression Vector Market Research Report
By Type
K. Lactis Expression Vectors, Pichia Pastoris Expression Vectors, Saccharomyces Cerevisiae Expression Vectors, Others
By Application
Therapeutic, Research, Industrial
By Companies
Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), New England Biolabs (U.S.), Merck Millipore (U.S.), QIAGEN (Netherlands), Clontech Laboratories, Inc. (U.S.), DNA2.0 (U.S.), GenScript USA Inc. (U.S.)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Yeast Expression Vector Market Report Segments:
The global Yeast Expression Vector market is segmented on the basis of:
Types
K. Lactis Expression Vectors, Pichia Pastoris Expression Vectors, Saccharomyces Cerevisiae Expression Vectors, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Therapeutic, Research, Industrial
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific, Inc. (U.S.)
- Promega Corporation (U.S.)
- Sigma-Aldrich Corporation (U.S.)
- Agilent Technologies (U.S.)
- Bio-Rad Laboratories (U.S.)
- New England Biolabs (U.S.)
- Merck Millipore (U.S.)
- QIAGEN (Netherlands)
- Clontech Laboratories, Inc. (U.S.)
- DNA2.0 (U.S.)
- GenScript USA Inc. (U.S.)
Highlights of The Yeast Expression Vector Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- K. Lactis Expression Vectors
- Pichia Pastoris Expression Vectors
- Saccharomyces Cerevisiae Expression Vectors
- Others
- By Application:
- Therapeutic
- Research
- Industrial
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Yeast Expression Vector Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A yeast expression vector is a DNA construct that can be used to express proteins in yeast. Yeast expression vectors typically comprise one or more promoter sequences, which are responsible for directing the transcription of the inserted genes into mRNA. The resulting mRNA is then translated into protein by the yeast cell.
Some of the major players in the yeast expression vector market are Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), Sigma-Aldrich Corporation (U.S.), Agilent Technologies (U.S.), Bio-Rad Laboratories (U.S.), New England Biolabs (U.S.), Merck Millipore (U.S.), QIAGEN (Netherlands), Clontech Laboratories, Inc. (U.S.), DNA2.0 (U.S.), GenScript USA Inc. (U.S.).
The yeast expression vector market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Yeast Expression Vector Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Yeast Expression Vector Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Yeast Expression Vector Market - Supply Chain
4.5. Global Yeast Expression Vector Market Forecast
4.5.1. Yeast Expression Vector Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Yeast Expression Vector Market Size (000 Units) and Y-o-Y Growth
4.5.3. Yeast Expression Vector Market Absolute $ Opportunity
5. Global Yeast Expression Vector Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Yeast Expression Vector Market Size and Volume Forecast by Type
5.3.1. K. Lactis Expression Vectors
5.3.2. Pichia Pastoris Expression Vectors
5.3.3. Saccharomyces Cerevisiae Expression Vectors
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Yeast Expression Vector Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Yeast Expression Vector Market Size and Volume Forecast by Application
6.3.1. Therapeutic
6.3.2. Research
6.3.3. Industrial
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Yeast Expression Vector Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Yeast Expression Vector Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Yeast Expression Vector Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Yeast Expression Vector Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Yeast Expression Vector Demand Share Forecast, 2019-2026
9. North America Yeast Expression Vector Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Yeast Expression Vector Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Yeast Expression Vector Market Size and Volume Forecast by Application
9.4.1. Therapeutic
9.4.2. Research
9.4.3. Industrial
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Yeast Expression Vector Market Size and Volume Forecast by Type
9.7.1. K. Lactis Expression Vectors
9.7.2. Pichia Pastoris Expression Vectors
9.7.3. Saccharomyces Cerevisiae Expression Vectors
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Yeast Expression Vector Demand Share Forecast, 2019-2026
10. Latin America Yeast Expression Vector Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Yeast Expression Vector Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Yeast Expression Vector Market Size and Volume Forecast by Application
10.4.1. Therapeutic
10.4.2. Research
10.4.3. Industrial
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Yeast Expression Vector Market Size and Volume Forecast by Type
10.7.1. K. Lactis Expression Vectors
10.7.2. Pichia Pastoris Expression Vectors
10.7.3. Saccharomyces Cerevisiae Expression Vectors
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Yeast Expression Vector Demand Share Forecast, 2019-2026
11. Europe Yeast Expression Vector Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Yeast Expression Vector Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Yeast Expression Vector Market Size and Volume Forecast by Application
11.4.1. Therapeutic
11.4.2. Research
11.4.3. Industrial
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Yeast Expression Vector Market Size and Volume Forecast by Type
11.7.1. K. Lactis Expression Vectors
11.7.2. Pichia Pastoris Expression Vectors
11.7.3. Saccharomyces Cerevisiae Expression Vectors
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
1.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Yeast Expression Vector Demand Share, 2019-2026
12. Asia Pacific Yeast Expression Vector Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Yeast Expression Vector Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Yeast Expression Vector Market Size and Volume Forecast by Application
12.4.1. Therapeutic
12.4.2. Research
12.4.3. Industrial
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Yeast Expression Vector Market Size and Volume Forecast by Type
12.7.1. K. Lactis Expression Vectors
12.7.2. Pichia Pastoris Expression Vectors
12.7.3. Saccharomyces Cerevisiae Expression Vectors
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Yeast Expression Vector Demand Share, 2019-2026
13. Middle East & Africa Yeast Expression Vector Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Yeast Expression Vector Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Yeast Expression Vector Market Size and Volume Forecast by Application
13.4.1. Therapeutic
13.4.2. Research
13.4.3. Industrial
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Yeast Expression Vector Market Size and Volume Forecast by Type
13.7.1. K. Lactis Expression Vectors
13.7.2. Pichia Pastoris Expression Vectors
13.7.3. Saccharomyces Cerevisiae Expression Vectors
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Yeast Expression Vector Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Yeast Expression Vector Market: Market Share Analysis
14.2. Yeast Expression Vector Distributors and Customers
14.3. Yeast Expression Vector Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher Scientific, Inc. (U.S.)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Promega Corporation (U.S.)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sigma-Aldrich Corporation (U.S.)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Agilent Technologies (U.S.)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Bio-Rad Laboratories (U.S.)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. New England Biolabs (U.S.)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Merck Millipore (U.S.)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. QIAGEN (Netherlands)
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Clontech Laboratories, Inc. (U.S.)
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. DNA2.0 (U.S.)
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. GenScript USA Inc. (U.S.)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
